251 related articles for article (PubMed ID: 18349828)
1. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
[TBL] [Abstract][Full Text] [Related]
2. VEGF
Boudria A; Abou Faycal C; Jia T; Gout S; Keramidas M; Didier C; Lemaître N; Manet S; Coll JL; Toffart AC; Moro-Sibilot D; Albiges-Rizo C; Josserand V; Faurobert E; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2019 Feb; 38(7):1050-1066. PubMed ID: 30194450
[TBL] [Abstract][Full Text] [Related]
3. VEGF111b, a new member of VEGFxxxb isoforms and induced by mitomycin C, inhibits angiogenesis.
Gu F; Li X; Kong J; Pan B; Sun M; Zheng L; Yao Y
Biochem Biophys Res Commun; 2013 Nov; 441(1):18-24. PubMed ID: 24125722
[TBL] [Abstract][Full Text] [Related]
4. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
[TBL] [Abstract][Full Text] [Related]
5. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
[TBL] [Abstract][Full Text] [Related]
6. VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth.
Li X; Gu F; Niu C; Wang Y; Liu Z; Li N; Pan B; He D; Kong J; Zhang S; Wang X; Yao Y; Zheng L
J Transl Med; 2015 May; 13():164. PubMed ID: 25990504
[TBL] [Abstract][Full Text] [Related]
7. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.
Konopatskaya O; Churchill AJ; Harper SJ; Bates DO; Gardiner TA
Mol Vis; 2006 May; 12():626-32. PubMed ID: 16735996
[TBL] [Abstract][Full Text] [Related]
8. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
[TBL] [Abstract][Full Text] [Related]
9. Balance of pro- versus anti-angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth.
Peiris-Pagès M; Harper SJ; Bates DO; Ramani P
J Pathol; 2010 Oct; 222(2):138-47. PubMed ID: 20662003
[TBL] [Abstract][Full Text] [Related]
10. VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo.
Rennel ES; Varey AH; Churchill AJ; Wheatley ER; Stewart L; Mather S; Bates DO; Harper SJ
Br J Cancer; 2009 Oct; 101(7):1183-93. PubMed ID: 19707198
[TBL] [Abstract][Full Text] [Related]
11. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human VEGF165b protein is an effective anti-cancer agent in mice.
Rennel ES; Hamdollah-Zadeh MA; Wheatley ER; Magnussen A; Schüler Y; Kelly SP; Finucane C; Ellison D; Cebe-Suarez S; Ballmer-Hofer K; Mather S; Stewart L; Bates DO; Harper SJ
Eur J Cancer; 2008 Sep; 44(13):1883-94. PubMed ID: 18657413
[TBL] [Abstract][Full Text] [Related]
13. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
14. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
[TBL] [Abstract][Full Text] [Related]
16. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term.
Bates DO; MacMillan PP; Manjaly JG; Qiu Y; Hudson SJ; Bevan HS; Hunter AJ; Soothill PW; Read M; Donaldson LF; Harper SJ
Clin Sci (Lond); 2006 May; 110(5):575-85. PubMed ID: 16451124
[TBL] [Abstract][Full Text] [Related]
17. The anti-angiogenic isoforms of VEGF in health and disease.
Qiu Y; Hoareau-Aveilla C; Oltean S; Harper SJ; Bates DO
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1207-13. PubMed ID: 19909248
[TBL] [Abstract][Full Text] [Related]
18. A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma.
Montemagno C; Durivault J; Gastaldi C; Dufies M; Vial V; He X; Ambrosetti D; Kamenskaya A; Negrier S; Bernhard JC; Borchiellini D; Cao Y; Pagès G
Mol Oncol; 2023 Jul; 17(7):1379-1401. PubMed ID: 36810959
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.
Hamdollah Zadeh MA; Amin EM; Hoareau-Aveilla C; Domingo E; Symonds KE; Ye X; Heesom KJ; Salmon A; D'Silva O; Betteridge KB; Williams AC; Kerr DJ; Salmon AH; Oltean S; Midgley RS; Ladomery MR; Harper SJ; Varey AH; Bates DO
Mol Oncol; 2015 Jan; 9(1):167-78. PubMed ID: 25224594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
